IVD (in vitro diagnostics) market settles down to steady but modest growth after the roller-coaster ride of the last decade
This article was originally published in Clinica
The in vitro diagnostics (IVDs) market worldwide is predicted to enjoy a modest 5% annual rise over the next five years, having weathered severe setbacks in 1996, when the worldwide market actually declined by 2%. This drop was the more surprising as it followed sales growth in double digits during the 1980s and early 1990s, according to information compiled by Theta Reports.
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.